在IIB,IIC和IIIA阶段的结肠癌中,分期悖论和复发模式:一个回顾性队列研究
Yu-Tso Liao1,2, John Huang3, Ji-Shiang Hung3
1Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
International journal of colorectal disease
|October 13, 2024
概括
患有IIB/C期结肠癌的患者的生存率比IIIA期更差. 这项研究发现,由于复发率较高,在IIB/C期结肠癌中可能需要加强化疗.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 癌症研究 癌症研究
背景情况:
- 结肠癌的分期对于预后和治疗决策至关重要.
- 一个矛盾的发现存在于IIB/C期结肠癌的生存率低于IIIA期.
研究的目的:
- 为了调查IIB,IIC和IIIA阶段结肠癌的瘤结果.
- 确定导致结肠癌观察到的分期悖论的因素.
主要方法:
- 从2011年1月至2019年12月对282名结肠癌患者 (IIB,IIC,IIIA阶段) 的回顾性分析.
- 检查包括手术切除,淋巴结产量和化疗在内的因素.
主要成果:
- 第IIB/C期结肠癌患者表现出较高的CEA水平,较大的瘤,更多的阻塞和增加的局部区域复发.
- 与IIIA相比,在IIB/C阶段观察到明显较低的10年地方区域无复发和癌症特异性存活率.
- 即使在R0切除,充分的淋巴结收获 (≥12) 和化疗后,分期悖论仍然存在.
结论:
- 阶段IIB/C结肠癌显示出较差的瘤结果和更高的复发率.
- 强化,量身定制的化疗建议用于IIB/C期结肠癌患者,以解决特定的复发模式.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Comparing the Survival Analysis of Two or More Groups
156
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
156


